Bespoke Extracts (BSPK) Long-Term Deferred Tax (2018 - 2022)
Bespoke Extracts (BSPK) reported Long-Term Deferred Tax of $1.4 million for Q4 2022, up 22.06% sequentially from $1.2 million in Q3 2021.
Bespoke Extracts (BSPK) Long-Term Deferred Tax (2018 - 2022) Analysis & Trends
Bespoke Extracts (BSPK) has 5 years of Long-Term Deferred Tax data on file, last reported at $1.4 million in Q4 2022.
- For the quarter ending Q4 2022, Long-Term Deferred Tax changed N/A year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2022 stood at $1.4 million (changed N/A YoY), and the FY2022 full-year result was $1.4 million, up 25.65% from the prior year.
- Long-Term Deferred Tax climbed to $1.4 million in Q4 2022, from $1.2 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.4 million in Q4 2022 to a low of $597359.0 in Q3 2018.
- A 5-year average of $1.0 million and a median of $958660.0 in 2020 frame the typical range for Long-Term Deferred Tax.
- Across the five-year window, Long-Term Deferred Tax surged 40.95% in 2019 and rose 13.86% in 2020, its largest moves.
- Tracing BSPK's Long-Term Deferred Tax over 5 years: stood at $597359.0 in 2018, then jumped by 40.95% to $842000.0 in 2019, then climbed by 13.86% to $958660.0 in 2020, then grew by 23.34% to $1.2 million in 2021, then advanced by 22.06% to $1.4 million in 2022.
- Business Quant data shows BSPK's Long-Term Deferred Tax at $1.4 million in Q4 2022, $1.2 million in Q3 2021, and $958660.0 in Q3 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.44 Mn |
| Aug 31, 2021 | 1.18 Mn |
| Aug 31, 2020 | 958,660.00 |
| Aug 31, 2019 | 842,000.00 |
| Aug 31, 2018 | 597,359.00 |